In addition to the important role of leukotrienes as mediators in allergy and inflmmation, these compounds are also linked to pathophysiological events in the brain including cerebral ischemia, brain edema, and increased permeability of the blood-brain barrier in brain tumors. Although brain tumors have been shown to secrete leukotrienes, no studies to date have provided evidence for the tumor expression of genes encoding enzymes involved in leukotriene production. Therefore, the present study determined the abundance of the mRNA for arachidonate 5-lipoxygenase (5-LO; arachidonate:oxygen 5-oxidoreductase, EC 1.13.11.34), which is the rate-limiting enzyme in leukotriene synthesis, in a series of human brain tumors. Macrophage/monocyte infiltration of the tumor was estimated by measuring the abundance of the transcript for the 91-kDa glycoprotein phagocyte-specific oxidase (gp91-phox), which is the phagocyte-specific cytochrome Overall, the present study supports the hypothesis that the 5-LO gene product may play a role in human tumor-induced brain edemas and provides evidence for tumor-associated expression of high molecular weight 5-LO transcripts in human brain tumors.Leukotrienes, important mediators of allergy and inflammation, are synthesized from arachidonic acid by 5-lipoxygenation to 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid (5-HPETE) and to leukotriene A4 (1-3). The limiting step in this reaction is catalyzed by the enzyme arachidonate 5-lipoxygenase (5-LO; arachidonate:oxygen 5-oxidoreductase, EC 1.13.11.34), whose gene was recently cloned from human lung and HL-60 cDNA libraries (4, 5). The expression of the 5-LO transcript was correlated with the cellular synthesis of leukotrienes (6). Although the product of the 5-LO gene is mainly found in leukocytes, lung, and placenta (1, 4), it has been postulated that metabolites of 5-LO may be involved in the brain with respect to modulation of the release of neurotransmitters (7,8). This is supported by the findings that immunoreactive leukotriene C4 is present in the nerve endings in the median eminence and in cell bodies in the preoptic area (9). Although indirect evidence for leukotriene production in neuronal tissue was obtained in experimental animals (9, 10) and humans (11), no direct determination of the 5-LO gene product has yet been performed for the human or experimental animal brain. Therefore, one of the purposes of the present study was to measure the abundance of the 5-LO transcript in bovine and human brain. Leukotrienes have also been linked to pathophysiological events in the brain. The concentration ofleukotrienes in brain is increased in cerebral ischemia (12). Leukotrienes also play a role in brain edema (13,14). Moreover, administration of leukotriene C4 selectively increases the permeability of the blood-brain barrier in brain tumors (15), suggesting that these molecules may mediate the vasogenic edema associated with brain tumors. Cerebral meningiomas and astrocytomas are hypothesized to release cysteinylleukotrienes to blood...